+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

LG Electronics Inc (066570) - Financial and Strategic SWOT Analysis Review

LG Electronics Inc (066570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

LG Electronics Inc (LG Electronics) manufactures and distributes consumer electronics and home appliances. The company’s product portfolio comprises televisions, monitors, laptops, refrigerators, audio and beauty appliances, video equipment, washing machines, air conditioners, dishwashers, water purifiers, and vacuum cleaners. It also offers vehicle components, information displays, substrate and material, motor and sensor components, optic solutions, automotive components, and camera modules. The company offers its products under the LG InstaView, UVnano, AI Direct Drive, and CordZero brands. It has business presence across Europe, the Americas, the Middle East, Africa, and Asia-Pacific. LG Electronics is headquartered in Seoul, South Korea.

LG Electronics Inc Key Recent Developments

  • Jun 15, 2026: Jackery and Homey Partner to Advance Plug-in Home Battery Integration in Europe
  • May 20, 2026: LG Aligns With UAE Energy Conservation Goals, Championing Efficient Cooling Solutions
  • Apr 28, 2026: LG HVAC Engineers Prioritize Safety and Innovation in Harsh Middle East Conditions
  • Jan 27, 2026: LG Advances Energy-Efficient District Cooling in the GCC with Chillers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Celltrion Inc - Key Facts
  • Celltrion Inc - Key Employees
  • Celltrion Inc - Key Employee Biographies
  • Celltrion Inc - Major Products and Services
  • Celltrion Inc - History
  • Celltrion Inc - Company Statement
  • Celltrion Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Celltrion Inc - Business Description
  • Business Segment: Biopharmaceutical Medicines
  • Overview
  • Performance
  • Business Segment: Chemical Medicines
  • Overview
  • Performance
  • Business Segment: Other
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Central and South America
  • Performance
  • Geographical Segment: Domestic Market
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: North America
  • Performance
  • R&D Overview
  • Celltrion Inc - Corporate Strategy
  • Celltrion Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Celltrion Inc - Strengths
  • Celltrion Inc - Weaknesses
  • Celltrion Inc - Opportunities
  • Celltrion Inc - Threats
  • Celltrion Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Celltrion Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 15, 2026: Celltrion Launches Two New Anticancer Drugs in Vietnam Accelerating Targeting of Global Pharma Emerging Markets in Asia and Latin America
  • May 27, 2026: Celltrion Science & Innovation Day 2026' Held Analysts and Institutional Investors Focus on 'New Drug Valuations
  • May 26, 2026: Celltrion Introduces AI to Three Major Areas: New Drug Development, Manufacturing, and Administration; Establishes Differentiated Systems for Each Task to Expand Global Competitiveness
  • May 13, 2026: Celltrion Included in Dow Jones Sustainability World Index for Two Consecutive Years Proving Responsible Management Through 'Global Standard' ESG Evaluation
  • May 06, 2026: Celltrion Records 1.145 Trillion Won in Revenue and 321.9 Billion Won in Operating Profit in the First Quarter
  • Apr 23, 2026: Celltrion Enters Patient Dosage for All 3 New ADC Drugs Clinical Trials on Track, Accelerating Leap to Global New Drug Company
  • Apr 16, 2026: Celltrion Sees Widespread Prescriptions for Key Product Lines in Europe Expectations for Success of High-Profit New Products Growing Driven by Field-Oriented Direct Sales Performance
  • Apr 15, 2026: Celltrion Selected Only in Korea for Top 1% in Biotechnology Sector of S&P ESG Evaluation Recognized for Practicing Top-Tier Global ESG Management
  • Mar 24, 2026: Celltrion Announces KRW 1.2Tn Expansion of New DS Production Facilities in Songdo; Adds 180,000L of DS capacity, bringing total capacity to 570,000L
  • Mar 18, 2026: Celltrion Healthcare Japan and CMIC Group Sign MOU to Expand Biosimilars in Japan
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Celltrion Inc, Key Facts
  • Celltrion Inc, Key Employees
  • Celltrion Inc, Key Employee Biographies
  • Celltrion Inc, Major Products and Services
  • Celltrion Inc, History
  • Celltrion Inc, Other Locations
  • Celltrion Inc, Subsidiaries
  • Celltrion Inc, Key Competitors
  • Celltrion Inc, Ratios based on current share price
  • Celltrion Inc, Annual Ratios
  • Celltrion Inc, Interim Ratios
  • Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Celltrion Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Celltrion Inc, Performance Chart (2021 - 2025)
  • Celltrion Inc, Ratio Charts
  • Celltrion Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Celltrion Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026